This is a match-making section for JPIAMR 14th call - Disrupting drug Resistance Using Innovative Design (DRUID).
Human Health
in silico, in vitro, in vivo preclinical and clinical studies in human and in all veterinary settings
neuroblastoma; melanoma; murine models; immunotherapy;
Dr. Croce has a background appropriate to study the host-tumor interactions and the responses elicited by immune therapy-based treatments in preclinical models of cancer. She has the technical-scientific skills necessary for the in-depth study of populations constituting the TME and populations of the immune system that have both anti-tumor and pro-tumor activity in mice
Dr. Croce would like to join project immune therapy-based in preclinical models of cancer.
Submitted on 2022-01-21 14:28:34
« Return to the partner search tool